These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

224 related articles for article (PubMed ID: 33266321)

  • 21. Long noncoding RNA FLRL2 alleviated nonalcoholic fatty liver disease through Arntl-Sirt1 pathway.
    Chen Y; Chen X; Gao J; Xu C; Xu P; Li Y; Zhu Y; Yu C
    FASEB J; 2019 Oct; 33(10):11411-11419. PubMed ID: 31311301
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Microanatomy of the metabolic associated fatty liver disease (MAFLD) by single-cell transcriptomics.
    Wang L; Zhou K; Wu Q; Zhu L; Hu Y; Yang X; Li D
    J Drug Target; 2023 Apr; 31(4):421-432. PubMed ID: 36847649
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Identification of 8-miRNAs as biomarkers for nonalcoholic fatty liver disease.
    Yu Y; Zhu J; Liu J; Huang M; Wan JX
    J Cell Physiol; 2019 Aug; 234(10):17361-17369. PubMed ID: 30790285
    [TBL] [Abstract][Full Text] [Related]  

  • 24. A liver-specific long noncoding RNA with a role in cell viability is elevated in human nonalcoholic steatohepatitis.
    Atanasovska B; Rensen SS; van der Sijde MR; Marsman G; Kumar V; Jonkers I; Withoff S; Shiri-Sverdlov R; Greve JWM; Faber KN; Moshage H; Wijmenga C; van de Sluis B; Hofker MH; Fu J
    Hepatology; 2017 Sep; 66(3):794-808. PubMed ID: 28073183
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Integration of Multi-omics Data from Mouse Diversity Panel Highlights Mitochondrial Dysfunction in Non-alcoholic Fatty Liver Disease.
    Chella Krishnan K; Kurt Z; Barrere-Cain R; Sabir S; Das A; Floyd R; Vergnes L; Zhao Y; Che N; Charugundla S; Qi H; Zhou Z; Meng Y; Pan C; Seldin MM; Norheim F; Hui S; Reue K; Lusis AJ; Yang X
    Cell Syst; 2018 Jan; 6(1):103-115.e7. PubMed ID: 29361464
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Degradation of PHLPP2 by KCTD17, via a Glucagon-Dependent Pathway, Promotes Hepatic Steatosis.
    Kim K; Ryu D; Dongiovanni P; Ozcan L; Nayak S; Ueberheide B; Valenti L; Auwerx J; Pajvani UB
    Gastroenterology; 2017 Dec; 153(6):1568-1580.e10. PubMed ID: 28859855
    [TBL] [Abstract][Full Text] [Related]  

  • 27. A nonalcoholic fatty liver disease model in human induced pluripotent stem cell-derived hepatocytes, created by endoplasmic reticulum stress-induced steatosis.
    Parafati M; Kirby RJ; Khorasanizadeh S; Rastinejad F; Malany S
    Dis Model Mech; 2018 Sep; 11(9):. PubMed ID: 30254132
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Integrated Multichip Analysis Identifies Potential Key Genes in the Pathogenesis of Nonalcoholic Steatohepatitis.
    Ye J; Lin Y; Wang Q; Li Y; Zhao Y; Chen L; Wu Q; Xu C; Zhou C; Sun Y; Ye W; Bai F; Zhou T
    Front Endocrinol (Lausanne); 2020; 11():601745. PubMed ID: 33324350
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Disruption of hepatic small heterodimer partner induces dissociation of steatosis and inflammation in experimental nonalcoholic steatohepatitis.
    Magee N; Zou A; Ghosh P; Ahamed F; Delker D; Zhang Y
    J Biol Chem; 2020 Jan; 295(4):994-1008. PubMed ID: 31831621
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Knockdown of long non-coding RNA Gm10804 suppresses disorders of hepatic glucose and lipid metabolism in diabetes with non-alcoholic fatty liver disease.
    Li T; Huang X; Yue Z; Meng L; Hu Y
    Cell Biochem Funct; 2020 Oct; 38(7):839-846. PubMed ID: 32212193
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Comprehensive gene profiling of the metabolic landscape of humanized livers in mice.
    Jiang C; Li P; Ma Y; Yoneda N; Kawai K; Uehara S; Ohnishi Y; Suemizu H; Cao H
    J Hepatol; 2024 Apr; 80(4):622-633. PubMed ID: 38049085
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Roles of microRNAs in immunopathogenesis of non-alcoholic fatty liver disease revealed by integrated analysis of microRNA and mRNA expression profiles.
    Zhang YJ; Hu Y; Li J; Chi YJ; Jiang WW; Zhang F; Liu YL
    Hepatobiliary Pancreat Dis Int; 2017 Feb; 16(1):65-79. PubMed ID: 28119261
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [The role of cytochrome P450 in nonalcoholic fatty liver induced by high-fat diet: a gene expression profile analysis].
    Liu Y; Cheng F; Luo YX; Hu P; Ren H; Peng ML
    Zhonghua Gan Zang Bing Za Zhi; 2017 Apr; 25(4):285-290. PubMed ID: 28494548
    [No Abstract]   [Full Text] [Related]  

  • 34. Integrated Analysis of Key Genes and Pathways Involved in Nonalcoholic Steatohepatitis Improvement After Roux-en-Y Gastric Bypass Surgery.
    Chen F; Zhou Y; Wu Z; Li Y; Zhou W; Wang Y
    Front Endocrinol (Lausanne); 2020; 11():611213. PubMed ID: 33603714
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Long Non-Coding RNA Profiling in a Non-Alcoholic Fatty Liver Disease Rodent Model: New Insight into Pathogenesis.
    Chen Y; Huang H; Xu C; Yu C; Li Y
    Int J Mol Sci; 2017 Jan; 18(1):. PubMed ID: 28275212
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Identification of Accessible Hepatic Gene Signatures for Interindividual Variations in Nutrigenomic Response to Dietary Supplementation of Omega-3 Fatty Acids.
    Shi Y; Li P; Jiang CF; Chen Y; Ma Y; Gupta N; Ruan X; Cao H
    Cells; 2021 Feb; 10(2):. PubMed ID: 33671567
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Inhibiting Interleukin 11 Signaling Reduces Hepatocyte Death and Liver Fibrosis, Inflammation, and Steatosis in Mouse Models of Nonalcoholic Steatohepatitis.
    Widjaja AA; Singh BK; Adami E; Viswanathan S; Dong J; D'Agostino GA; Ng B; Lim WW; Tan J; Paleja BS; Tripathi M; Lim SY; Shekeran SG; Chothani SP; Rabes A; Sombetzki M; Bruinstroop E; Min LP; Sinha RA; Albani S; Yen PM; Schafer S; Cook SA
    Gastroenterology; 2019 Sep; 157(3):777-792.e14. PubMed ID: 31078624
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Long noncoding RNAs associated with nonalcoholic fatty liver disease in a high cholesterol diet adult zebrafish model.
    An HJ; Lee YJ; Choe CP; Cho HK; Song DH
    Sci Rep; 2021 Nov; 11(1):23005. PubMed ID: 34837012
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Systems-level organization of non-alcoholic fatty liver disease progression network.
    Shubham K; Vinay L; Vinod PK
    Mol Biosyst; 2017 Aug; 13(9):1898-1911. PubMed ID: 28745372
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Genomics of human fatty liver disease reveal mechanistically linked lipid droplet-associated gene regulations in bland steatosis and nonalcoholic steatohepatitis.
    Sahini N; Borlak J
    Transl Res; 2016 Nov; 177():41-69. PubMed ID: 27376874
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.